With no effective therapy to prevent or treat ureteral stricture (US), a multifactorial fibrotic disease after iatrogenic injury of the ureter, the need for new therapies is 
represent valid and successful treatments for complicated US. However, the major drawback of these techniques is the recurrent US because of the formation of hyperplastic muscle or scar tissue in anastomotic stoma. 2 Anti-fibrotic drugs, such as glucocorticoids, 5 captopril 6 and halofuginone 7 have been tested to limit re-stricturing after US surgery. Regrettably, none of these drugs exhibit validation of therapeutic benefit thus have not been applied in the clinic.
Mesenchymal stem cells (MSCs) have been widely studied for treating tissue defects and excessive fibrosis, due to their ability to differentiate into cells needed for tissue repair and secrete a broad range of bioactive molecules (eg, growth factors, cytokines and chemokines). 8, 9 However, with the recognition that only limited
MSCs are recruited in the injury site after MSCs transplanted, 10 many investigators have suggested its therapeutic effects on tissue repair might be rather by stimulating the activity of tissue-resident recipient cells via paracrine mechanisms. 11, 12 Extracellular vesicles (EVs) are small membrane vesicles originating from multivesicular bodies, which have been identified as a new kind of major paracrine factor naturally secreted by cells. 12, 13 EVs can be categorized into exosomes (40-200 nm) , microvesicles (50- 1000 nm) and apoptotic bodies (50-5000 nm), etc.
14 Recently, the therapeutic capacity of MSCs-derived EVs (MSCEVs) to treat fibrosis has been studied extensively. These cell-free agents have shown promise in decreasing fibrosis in pre-clinical models of lung fibrosis, liver fibrosis, cardiac fibrosis, kidney fibrosis and skin fibrosis. [15] [16] [17] [18] [19] Based on above information, we hypothesized that MSC-EVs such as bone marrow MSCs-derived EVs could reduce US formation.
With this scope, we try to develop a rodent model mimicking US after iatrogenic ureteral injury and to investigate the efficacy of administration of MSC-EVs to prevent fibrosis.
| MATERIALS AND METHODS

| MSCs and MSC-EVs preparation
Sprague Dawley (SD) rat bone marrow MSCs line (Cat. No SCSP-
402) was obtained from the Cell Bank of Chinese Academy of Sciences (Shanghai, China). MSCs were cultured in a-Minimal
Essential Medium (Gibco/Thermo Fisher Scientific) with 1% L-glutamine supplemented with 10% Exosome-depleted foetal bovine serum (System Biosciences, NO. 082615). Once at 80% confluence, MSCs were starved (replaced with serum-free medium) overnight and then the conditioned medium was collected. Then, MSCs-EVs from the supernatant were isolated by the ExoQuick TM (System Biosciences) reagent. EVs were further detected by a transmission electron microscopy analysis (Hitachi, Japan), nanoparticle tracking analysis (Malvern NanoSight, UK) and EVs characteristic surface marker proteins (CD9, CD63 and CD81). For subsequent animal experiment, a dose of 3.5 9 10 6 MSCs from a 100 mm cell culture dish (80% of cell confluent) was administered for one animal; and an EVs dosing (25 lg protein, quantitated by the Micro Bicinchoninic Acid Protein Assay Kit (Pierce), diluted with 100 lL PBS) was determined by corresponding to the amount produced by 3.5 9 10 6 MSCs equivalents from cell culture supernatants. 
| Animals and ethical approval
| Study design
We established an original US animal model using microscopic vas- We preferred to do the injection using a 29-G insulin syringe (Becton, Dickinson and Company, USA) filled with 100 lL PBS/MSCs/ MSC-EVs.
| Magnetic resonance imaging assessment
All rats were scanned by Magnetic resonance imaging (MRI) at 2 weeks and 4 weeks following the treatment for assessing the presence of hydronephrosis. Based on the MRI images (sagittal, coronal and transverse section), the left renal pelvis volume (RPV) of each rat was quantified in accordance with a previously described method, 20 following the calculation formula: "maximum anteroposterior diameter" 9 "maximum length diameter" 9 "maximum transverse diameter" 9 0.523.
| Renal function test
Blood samples were collected from the inferior vena cava for detection of serum creatinine (Cr) and blood urea nitrogen (BUN) at 4 weeks after treatment. Cr and BUN were measured using Automated Chemistry Analyzers (Beckman Coulter Chemistry Analyzer AU5800, CA, USA) according to the manufacturer's instructions.
| Histology
After rats were killed, the stenotic tissue of the ureter segment (proximal and distal to the injury site, about 1.5 cm) and the homolateral kidney were harvested, fixed and further processed for histology.
Haematoxylin and eosin (HE) and immunohistochemical staining procedures were performed according to a standard protocol. The degree of US was evaluated by the quantification of the ureteral lumen diameter. We assessed the degree of tissue damage in the renal cortex and outer medulla (ie, tubular necrosis and tubular enlargements.) on a scale of 0 to 2 (none to marked) according to Toyohara et al's study. 21 The scoring of immunoreactivity was obtained by adding the score of positive cell percentages and staining intensities.
| qRT-PCR and Western blot
The mRNA and protein expression levels of collagen I (Col I), collagen III (Col III), fibronectin (Fib), transforming growth factor-b1 (TGF-b1) and Smad3 (phosphorylation of Smad3 (p-Smad3) was used in Western blot (WB)) in experimental ureter tissue samples were examined.
b-actin was employed as the internal normalization. The sequences of the PCR primers are as follows are listed in Table S1 . All the relevant antibodies were purchased from Abcam Biotechnology.
| Statistical analysis
The results were analysed using SSPS 16.0 software (SPSS, Inc., Chicago, IL) and expressed as mean AE standard deviation of the mean.
One-way analysis of variance followed by Bonferroni's multiple comparison tests was used to evaluate whether differences between groups were significant. Statistical significance was set at P < .05.
| RESULTS
| Characterization of MSC-EVs
Transmission electron microscopy revealed that EVs were grapelike clusters of vesicles with double layer membrane structure and 
| Animals
One rat of the MSCs group died due to perioperative infection after microscopic vascular clamp implantation. The body weight of rats at initial and 2 weeks after treatment did not differ significantly among the 4 groups (P > .05, for all). At 4 weeks after treatment, the body weight of the Sham group was significantly greater than that of the other three groups (P < .05, for all). The body weight of MSCs and MSC-EVs groups increased a slight but not statistically as compared with the US group (P = 1.000 and 1.000, respectively; Table S2 ).
| Mri
As listed in Figure 3 , the MSCs group and MSC-EVs treated group showed significantly less hydronephrosis in comparison with the US group at 2 weeks and 4 weeks after treatment. As expected, the Sham group had the lowest values of RPV, whereas the US group had the highest values of these parameters (Table 1) . Notably, the RPV values were statistically alleviated in the MSCs as well as MSCEVs treatment groups compared to the US group (P < .01 for all).
Furthermore, the MSC-EVs group had the better alleviation of hydronephrosis when compared to MSCs groups at 2 weeks and 4 weeks, but the difference was not statistically significant (P = 1.000, P = 1.000).
| Renal function
As shown in Figure S1A , MSCs and MSC-EVs rats exhibited lower but not statistically Cr than those in the US group at 4 weeks after injection (P = 1.000, P = .928). The BUN was significantly lower in
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F I G U R E 1 Ureteral stricture rat model. A, The upper ureter was exposed and positioned with a microscopic vascular clamp. B, After 3 d, the clamp was removed from the ureter via the initial incision LUO ET AL.
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both MSCs and MSC-EVs rats when compared to US group (P = .000, P = .000; Figure S1B ). No differences in Cr and BUN were observed between MSCs and MSC-EVs animals (P = 1.000, P = 1.000), indicating that MSC-EVs treatment had almost the same efficacy on preventing a deterioration of the renal function to that of MSCs. Figure 5D . Changes of renal structure in US rats were characterized by tubular dilation, tubular destroy, apoptosis and glomerulus atrophy, whereas these disorganizations were significantly improved in MSCs and MSC-EVs treated rats ( Figure 5C ).
Corresponding histological scoring of the areas with tubular necrosis and tubular enlargements in each group were listed in Figure 5E and F.
TGF-b1 is a recognized fibrosis factor. Col I, one of the extracellular matrix molecules, is a key biomarker during fibrosis process.
The experimental ureter from US rats showed significantly increased levels of Col I and TGF-b1 expression as compared to the Sham rats (P = .000, P = .000); MSCs and MSC-EVs treated groups showed a significant decrease in the number of Col I and TGF-b1 positive cells when compared with the US group (P < .05, for all). However, these immunoreactivity changes were not significantly different between
MSCs and MSC-EVs treatment group (P = 1.000, P = 1.000; Figure 6 ). 
| Gene and protein expression
| DISCUSSION
In the present study, we found that transplantation of a bolus dose of MSCs by intra-arterial route counteracts US formation through the anti-fibrotic action in a rat model. Importantly, we provided evidence that EVs derived from MSCs might be involved in this func- MSC-EVs might act as the therapeutic vectors regulating multiple fibrogenetic parameters and exerting anti-inflammatory, antioxidative, restoration of external matrix degradation and proangiogenic properties. 25, 26 Wound healing response including hemostasis, inflammation, proliferation and remodelling that need to restitute the homeostasis thus not to cause an excessive fibrosis and scarring. 27 Severe or repetitive ureteral injury can evolve into an irreversible fibrotic response which represents excessive accumulation of the epithelium and the surrounding tissues result in a narrowing of the ureteral lumen namely US. Fibrogenesis was characterized by activating and proliferating extracellular matrix-producing myofibroblasts, which can lead to several chronic pathologies such as permanent scarring and organ malfunction. 28 Many distinct triggers were identified to contribute to the development of a fibrotic disease. For US, ureteral inflammatory lesions, 29 ureteric intima ischaemia 30 
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Evidence from the literature suggests that EVs improve the recovery of organic function, enhance angiogenesis and inhibit apoptosis by delivering microRNAs, mRNAs and active proteins to orchestrate tissue repair. [44] [45] [46] Also, MSCs-derived EVs had a potent anti-inflammatory and pro-remodelling effect on cell phenotype, acting as the key immunomodulators in biological processes. 15 The capacity of EVs to halt pro-fibrotic pathways may have contributed to their specialty for "reprogramming" fibroblasts by residing in their unique microRNA and non-coding RNAs payload, fundamentally transforming the phenotype of these cells. 47, 48 Analyses of MSCs-derived EVs nucleic acid content demonstrated shuttle selected pattern of microRNAs may contribute to the 
